Zai Lab Limited
ZLAB
$26.75
$0.622.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.28% | -2.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.28% | -2.37% | |||
| Cost of Revenue | -5.58% | 5.33% | |||
| Gross Profit | 127.01% | -51.71% | |||
| SG&A Expenses | 12.01% | -23.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.27% | -8.00% | |||
| Operating Income | 2.51% | 17.06% | |||
| Income Before Tax | 15.92% | 40.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.92% | 40.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.92% | 40.70% | |||
| EBIT | 2.51% | 17.06% | |||
| EBITDA | 3.20% | 18.51% | |||
| EPS Basic | 16.78% | 43.66% | |||
| Normalized Basic EPS | 13.35% | 45.88% | |||
| EPS Diluted | 16.78% | 43.66% | |||
| Normalized Diluted EPS | 13.35% | 45.88% | |||
| Average Basic Shares Outstanding | 1.03% | 5.26% | |||
| Average Diluted Shares Outstanding | 1.03% | 5.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||